Sign In
Buy PBYI
$6.81
-0.170 (-2.44%)
At Close: Jun 03, 2026
LOS ANGELES--(BUSINESS WIRE)--The P III ExteNET Trial shows improved outcomes in patients with HER2+ early stage breast cancer who received ≥ 11 months of treatment with neratinib.
Puma Biotechnology Announces Publication of Abstracts on Neratinib for the 2021 ASCO Annual Meeting
05:05pm, Wednesday, 19'th May 2021
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announce the availability of three abstracts on the ASCO Annual Meeting website related to poster presentations on June 4, 2021.
Puma Biotechnology, Inc. (PBYI) CEO Alan Auerbach on Q1 2021 Results - Earnings Call Transcript
10:35pm, Thursday, 06'th May 2021
Puma Biotechnology, Inc. (PBYI) CEO Alan Auerbach on Q1 2021 Results - Earnings Call Transcript
Puma Biotech (PBYI) Q1 Earnings and Revenues Beat Estimates
08:17pm, Thursday, 06'th May 2021
Puma Biotech (PBYI) delivered earnings and revenue surprises of 37.93% and 31.03%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Tuesday, 04'th May 2021
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology reported inducement awards granted in April 2021 as required under Nasdaq Listing Rule 5635(c)(4) .
Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results
04:15pm, Thursday, 22'nd Apr 2021
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology will host a conference call/webcast at 1:30 p.m. PDT on May 6, 2021, following release of its 1Q-2021 financial results.
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
05:05pm, Tuesday, 13'th Apr 2021
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on April 12, 2021 the Compensation Committee of Puma's Board of Directors approved th
Puma Biotech (PBYI) Down 6.3% Since Last Earnings Report: Can It Rebound?
12:41pm, Saturday, 27'th Mar 2021
Puma Biotech (PBYI) reported earnings 30 days ago. What's next for the stock?
Celcuity Teams Up With MD Anderson, Novartis, Puma Biotech To Study New Drug Regimen In Breast Cancer
09:28am, Wednesday, 17'th Mar 2021
Celcuity Inc (NASDAQ: CELC) has announced a clinical trial collaboration with the MD Anderson Cancer Center, Novartis AG (NYSE: NVS), and Puma Biotechnology Inc (NASDAQ: PUMA) to conduct a P
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
05:15pm, Monday, 08'th Mar 2021
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology reported the grant of an inducement award approved by the BOD on March 4, 2021, as required by Nasdaq Listing Rule 5635(c)(4).
Polyphor Announces Financial Results for the Full-Year 2020
01:15am, Friday, 05'th Mar 2021
ALLSCHWIL, Switzerland, March 05, 2021 (GLOBE NEWSWIRE) -- Polyphor AG (SIX: POLN) a research driven clinical stage, Swiss biopharmaceutical company committed to discovering and developing best-in-cla
Puma Biotechnology to Present at the Barclays Global Healthcare Conference
04:15pm, Thursday, 04'th Mar 2021
LOS ANGELES--(BUSINESS WIRE)--Alan Auerbach, CEO & President, will present an overview of Puma Biotechnology at the virtual Barclays Global Healthcare Conference on March 11, 2021.
Puma Biotechnology to Present at the H.C. Wainwright Global Life Sciences Conference
04:20pm, Tuesday, 02'nd Mar 2021
LOS ANGELES--(BUSINESS WIRE)--Alan Auerbach will present an overview of Puma Biotechnology at H.C. Wainwright's Global Health Care Conf, available online beginning March 9, 2021.
Puma (PBYI) Q4 Loss Wider Than Expected, Nerlynx Sales Fall
11:22am, Friday, 26'th Feb 2021
Puma Biotech (PBYI) reports wider-than-expected fourth-quarter loss while sales beat estimates.
Puma Biotechnology's (PBYI) CEO Alan Auerbach on Q4 2020 Results - Earnings Call Transcript
10:02pm, Thursday, 25'th Feb 2021
Puma Biotechnology's (PBYI) CEO Alan Auerbach on Q4 2020 Results - Earnings Call Transcript
